National and Kapodistrian University of Athens
Η ανάπτυξη της μεθόδου μικροσυστοιχιών πυρηνικού και μιτοχονδριακού δεσοξυριβονουκλεϊκού οξέος (DNA microarrays) στη μελέτη των μιτοχονδριακών νοσημάτων
Abstract
dc:descriptionThe pivotal role of mitochondria in cell energy metabolism and the complex nature of their genetic regulation, by both the nuclear and the mitochondrial DNA, form the basis for the diverse clinical presentation and the unique genetics of mitochondrial diseases. Moreover, primary or secondary mitochondrial dysfunction has been associated with the pathogenesis of a variety of conditions, such as obesity, diabetes, cancer, neurodegeneration, cardiomyopathy, depression and aging. Despite their significance, diagnostic tools for assessing mitochondrial function remain limited and labor intensive, as they involve biochemical analyses on muscle biopsy specimens and molecular testing, available only at limited specialized centers world-wide. The present work describes the development and first application of the microarray technology in studying mitochondrial genomics. We developed a human mitochondria-focused microarray, with 501 nuclear encoded genes related to mitochondrial structure, biogenesis and function. For the validation of that method we studied gene expression profiles in dexamethasone-treated primary human skeletal myocytes, as an in vitro model of steroid-induced myopathy. Changes were observed in the expression of genes involved in protein synthesis, fatty acid metabolism, oxidative stress and apoptosis, while the most significant finding was the induction of the gene encoding for monoamine oxidase-A (MAO-A). MAO-A is the primary enzyme metabolizing catecholamines, other neurotransmitters and dietary amines, and its role in skeletal muscle remains largely unexplored. We report a significant induction of MAO-A gene transcription and protein synthesis, followed by increased enzymatic activity, leading to downstream hydrogen peroxide production. We suggest that MAO-A mediated oxidative stress can lead to skeletal muscle cell damage, representing a novel pathogenetic mechanism for glucocorticoid-induced myopathy and a potential target for therapeutic intervention. The experience from this first application of the mitochondrial microarray led to the design and development of a more advanced version, the hMitChip3, which contains 1135 genes related to mitochondria, including the newly cloned mtDNA-encoded genes. We believe that the mitochondrial microarray represents a novel and reliable tool for studying mitochondrial genomics.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Manoli, Irini
- Μανώλη, Ειρήνη
Subjects
dc:subject × 20- Μιτοχόνδρια
- Μικροσυστοιχίες
- Γενομική
- Μυοπάθεια
- Δεξαμεθαζόνη
- Γονιδιακή έκφραση
- Μονοαμινοξειδάση Α
- Υπεροξείδιο υδρογόνου
- Mitochondria
- Microarrays
- Genomics
- Myopathy
- Dexamethasone
- Gene expression
- Monoaminoxidase A (MAO-A)
- Hydrogen peroxide
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23625